Cargando…
A Proteomic Study of Human Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cancer of the skin. The incidence has been quadrupled with a 5-year mortality rate of 46%, presently there is no cure for metastatic disease. Despite the contribution of Merkel cell polyomavirus, the molecular events of MCC carcinogenesis a...
Autores principales: | Shao, Qiang, Byrum, Stephanie D., Moreland, Linley E., Mackintosh, Samuel G., Kannan, Aarthi, Lin, Zhenyu, Morgan, Michael, Stack, Brendan C., Cornelius, Lynn A., Tackett, Alan J., Gao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181674/ https://www.ncbi.nlm.nih.gov/pubmed/25284964 http://dx.doi.org/10.4172/jpb.1000291 |
Ejemplares similares
-
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
por: Kannan, Aarthi, et al.
Publicado: (2015) -
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
por: Sengupta, Deepanwita, et al.
Publicado: (2015) -
Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide
por: Udensi, Udensi K, et al.
Publicado: (2014) -
Time- and radiation-dose dependent changes in the plasma proteome after total body irradiation of non-human primates: Implications for biomarker selection
por: Byrum, Stephanie D., et al.
Publicado: (2017) -
Purification of a specific native genomic locus for proteomic analysis
por: Byrum, Stephanie D., et al.
Publicado: (2013)